Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Informatics Supports Adoption Of Genetics And Genomics Across Clinical Areas

    Diagnostics World News Contributed Commentary | As interest in and awareness of precision medicine sweeps the industry, healthcare leaders are applying the principals of precision oncology to other clinical areas—to great effect.

    Mar 19, 2020
  • Coronavirus Testing Picks Up in the U.S. Following Slow Start

    Diagnostics World News | The coronavirus outbreak continues to wreak havoc as diagnostic developers scramble to come up with tools to combat the spread of disease.

    Mar 17, 2020
  • FDA Announces Updates To COVID-19 Diagnostic Test Policy

    Diagnostics World News Brief | The FDA announced an update to their February 2020 policy on diagnostic testing for coronavirus in order to accelerate the availability of novel COVID-19 diagnostic tests developed by laboratories and commercial manufacturers during the public health emergency.

    Mar 17, 2020
  • University Of Cincinnati Researchers Develop Device For Diagnostics Via Smartphone

    Diagnostics World News | Engineers at the University of Cincinnati have developed a portable device that brings the capabilities of a diagnostics lab to the smartphone.

    Mar 13, 2020
  • Patient-Centric Approaches to Managing Digital Health Data: Updates from the Molecular Medicine Tri-Conference

    Diagnostics World News | The rapid emergence of electronic health record systems, genetic sequencing services, wearables and other digital health tools in recent years has generated more patient data than ever.

    Mar 12, 2020
  • Leveraging Artificial Intelligence and Machine Learning for Precise, Predictive Medicine: Updates from the Molecular Medicine Tri-Conference

    Diagnostics World News | Although artificial intelligence has generated plenty of buzz in biomedical research, thought leaders at the Molecular Medicine Tri-Conference in San Francisco last week showed that it’s more than just a flashy catchphrase.

    Mar 10, 2020
  • Human Longevity Inc. Changing Healthcare ‘One Patient At A Time’

    Diagnostics World News | Human Longevity Inc. launched six years ago with the goal of building a million-genome database replete with phenotypic and clinical data but is now laser focused on helping its clients live to be 100.

    Mar 6, 2020
  • Together, Doctors And AI Can Process “Helluvabytes” Of Data

    Diagnostics World News | Data is the most valuable resource on the market today, and there’s a lot of it. When it comes to processing health data, the solution may be neural networks. Not AI to replace doctors, says Eric Topol, but AI to empower doctors.

    Mar 5, 2020
  • Co-Diagnostics Presents Rapid Diagnostic Test For Coronavirus In San Francisco

    Diagnostics World News | Co-Diagnostics presented their new rapid diagnostic test for COVID-19 yesterday at the Molecular Medicine TriConference in San Francisco. The Salt Lake City, Utah, diagnostics company is among the many companies working on a rapid diagnostic test for COVID-19.

    Mar 4, 2020
  • Thermo Fisher Scientific To Acquire QIAGEN

    Diagnostics World News | QIAGEN has been acquired by Thermo Fisher Scientific in a deal valued at $11.5 billion, which includes the assumption of approximately $1.4 billion of net debt.

    Mar 3, 2020
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127 (current)
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy